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ORIGINAL ARTICLES
Introduction
Cervical smear screening substantially reduces the
morbidity and mortality rates of invasive cervical
carcinoma. The cumulative incidence of cervical
carcinoma was shown to decrease by 90.8% and
93.5% when smears were taken at 3-year and 1-year
intervals, respectively.1 Adab,2 however, has recently
reported that almost 50% of all women in Hong Kong
have never undergone a cervical smear test. And at
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Objective. To determine why invasive cervical carcinoma still occurs despite the availability of cervical smear
screening services.
Design. Questionnaire survey and retrospective study of patient records of women who attended a gynaeco-
logical oncology out-patients clinic from 13 February 1997 to 30 June 1997.
Setting. Public hospital, Hong Kong.
Patients. Ninety-nine women (median age 53 years; range, 30-79 years) who gave a history of squamous
cervical carcinoma.
Main outcome measures. The date of the last cervical smear test prior to the development of cervical car-
cinoma; reasons for non-attendance; attitudes to screening; and the stage and histological diagnosis of disease.
Results. Only 19 (19.2%) of the 99 patients had received routine cervical smear testing during the previous 3
years prior to their disease; 76 (76.8%) had not been tested within the past 10 years. The major reasons for
not having been tested included being unaware that cervical carcinoma is preventable by screening or can be
asymptomatic, being too busy to go for screening, and not knowing where to go for screening. After receiving
treatment, 17 (17.2%) of the 99 patients still thought screening was unnecessary and 20 (20.2%) had no idea
how frequently smears should be taken.
Conclusion. The greatest barrier to effective cervical screening is patient ignorance. Public education about
cervical smear screening in Hong Kong is needed.
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the Queen Mary Hospital, 109 and 85 new patients
presented with invasive cervical carcinoma in 1995
and 1996, respectively.3 The aim of this study was to
determine whether the continued occurrence of cer-
vical carcinoma is accountable by a failure to screen,
and to identify the reasons for patient non-compliance
to cervical screening.
Methods
All patients with a history of squamous cervical
carcinoma who attended the Sai Ying Pun Gynaeco-
logical Oncology Out-patients Clinic of the Tsan Yuk
Hospital from 13 February 1997 to 30 June 1997 were
enrolled in the study. Participants were interviewed
using a standardised questionnaire. The following data
were obtained: whether cervical smear screening had
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been performed prior to the diagnosis of cervical
carcinoma and if so, the date of the last cervical smear
test; the reason(s) for not participating in cytology
screening; and each patient’s current attitude to screen-
ing. The correlation between the questionnaire answers
and the disease stage and histology (as retrieved
from previous patient admission records) was then
calculated by using the Pearson’s correlation test.
Results
A total of 127 patients were seen during the study
period. Histological examinations of biopsy samples
had identified 99 (78.0%) squamous carcinomas, 21
(16.5%) adenocarcinomas, 5 (3.9%) adenosquamous
carcinomas, 1 (0.8%) lymphoma, and 1 (0.8%) clear
cell carcinoma. All 99 patients who had a history of
squamous cervical carcinoma participated in this
study, and all of them had been treated by either
surgery or radiotherapy at the Queen Mary Hospital.
Forty-nine (49.5%), 18 (18.2%), and 32 (32.3%)
patients had had the cervical cancer diagnosed within
5 years, between 5 and 10 years, and beyond 10 years
of the present study, respectively. The median patient
age was 53 years (range, 30-79 years).
Eighty-five (85.9%) of the 99 patients had presented
because of the presence of vaginal bleeding or dis-
charge, whereas 11 (11.1%) patients had the diagno-
sis of cervical carcinoma made during their regular
check-up. The remaining three (3.0%) patients were
found to have the disease during a body check-up that
they had attended for various reasons: one patient
attended following a recommendation by friends, the
second attended for ‘advancing age’, and the third
attended because a relative had recently had a gynae-
cological disease diagnosed. Ten (71.4%) of these 14
asymptomatic patients had stage I disease; of the
remaining four, one had never been screened previ-
ously and three had received only one other smear
test 1 to 3 years earlier.
Only 19 (19.2%) of the 99 patients had been
screened for cervical cancer within the previous 3 years
and the results of all 19 patients had been negative.
Seventy-six (76.8%) patients had not been screened
for 10 years or more (Table 1). The 10-year delay in
screening was found in all age-groups (P>0.05). Table
2 shows the relationship between the interval from
the last smear test to disease diagnosis and the disease
stage. There was no significant correlation between
the two variables, possibly due to the small sample
size. Failure to screen seemed to be an important
problem, not only for patients whose disease had
been treated previously, but also for those with recently
diagnosed disease. Fortunately, there were no cases
of advanced disease that had been missed by cervical
screening.
Common reasons given by patients for not having
regular screening included being unaware of the
need for regular screening (83.8%), not having any
symptoms (82.5%), being too busy (23.8%), and not
knowing where to go for screening (26.3%). Two
(2.0%) patients had previously attended family
planning clinics to receive a gynaecological check-up
but their request for cervical screening was refused
because they no longer required contraception; they
then presumed that routine screening was no longer
necessary.
Table 1. Interval between last smear and disease diagnosis of patients with squamous cervical carcinoma
Interval (years) No. of patients*
Age
<35 years 35-44 years 45-54 years 55-64 years ≥65 years Total
≤3 2 (1) 9 (6) 2 (1) 4 (1) 2 19 (9)
4-10 0 1 2 1 0 4 (0)
>10 5 12 (3) 21 (2) 22 16 76 (5)
Total 7 (1) 22 (9) 25 (3) 27 (1) 18 (0) 99 (14)
* Figures in parentheses denote the No. of patients whose disease was diagnosed by screening
Table 2. Distribution of interval from last smear to disease diagnosis according to disease stage
Interval (years) No. of patients*
Disease stage
I II III Unstaged Total
≤3 9 (6) 8 (3) 0 2 19 (9)
4-10  1 3 0 0 4 (0)
>10 35 (4) 26 (1) 12 3 76 (5)
Total 45 (10) 37 (4) 12 (0) 5 (0) 99 (14)
* Figures in parentheses denote the No. of patients whose disease was diagnosed by screening
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Sixty-one (61.6%) of the 99 patients stated that
they would advise their families and friends to be
screened routinely for cervical cancer, but 11 (18.0%)
of these patients did not know where the service
was available (Table 3). Seventeen (17.2%) patients
considered routine screening to be unnecessary if
symptoms were absent. When asked about the
frequency of routine smears that patients considered
appropriate, 37 (37.4%) either thought smears were
unnecessary or had no idea about the appropriate
frequency.
Discussion
Despite the availability of the cervical smear screen-
ing test, cervical cancer is still being diagnosed in
Hong Kong. Possible causes are the failure of patients
to attend screening programmes, rapid tumour growth
between subsequent smear tests, faulty technique
when taking and preparing the smear, error in inter-
pretation of the smear results by the cytopathologist,
a failure of the clinician to take appropriate action
for abnormal smear results, and non-compliance of
patients to the doctor’s advice or follow-up. In this
study, 76.8% of patients with squamous cervical car-
cinoma—a cancer which is theoretically preventable
by cervical cytology screening—had not received a
smear test for 10 years or longer. This observation
strongly suggests that non-attendance to routine
cervical screening is a major risk factor for the
development of squamous cervical carcinoma. Non-
attendance to screening occurred in all age-groups.
Common reasons for not attending screening included
patients being unaware of the need for screening,
the absence of symptoms, patients not knowing where
to go to, and time constraints.
The two patients who had attended family plan-
ning clinics for routine gynaecological examination
had misinterpreted the information given by the staff;
not being offered the smear test had made the patients
believe that they were no longer at risk for the devel-
opment of cervical cancer. In addition, 38 (38.4%)
patients indicated that they would not advise their
families and friends to attend screening, and 17 (44.7%)
of these patients believed that screening was not
necessary. These findings represent an important
potential problem, because the patients’ misunderstand-
ing can be passed onto their friends and families. A
substantial proportion (12.1%) of patients indicated
that they did not know where screening was offered.
A majority (61; 61.6%) of the 99 patients suggested
that their family members should have cervical
screening every year or more frequently. Although
this frequency of testing is not appropriate or cost-
effective, the patients’ reply is understandable in
view of their disease history. Their reply, however,
again reflects the confusion among the general popu-
lation about screening, no doubt owing to inadequate
education about cervical cancer and the lack of an
effective screening programme in Hong Kong. All
19 women who had been screened within the previ-
ous 3 years had presented with vaginal bleeding or
discharge, an observation which emphasises the need
for patients to seek medical advice if these symptoms
are present, despite having had previous negative smear
test results.
There are now many services in Hong Kong that
provide opportunistic or voluntary cervical cytology
screening tests. These services include the Well-
Woman Clinics and Mother-and-Child Health Centres,
Table 3. Response given by patients when asked whether they would advise their families and friends to be screened for cervical
cancer
(3a) Response of “yes” (61/99; 61.6%)
Site of screening Patients, n=61
No. (%)
Government clinics or mother-and-child health centres 21 (34.4)
Family Planning Association 10 (16.4)
Private sector 7 (11.5)
Any of the above 12 (19.7)
No idea where the service was available 11 (18.0)
(3b) Response of “no” (38/99; 38.4%)
Reason Patients, n=38
No. (%)
They do not need my advice 14 (36.8)
No idea where screening is available 1 (2.6)
Screening is unnecessary 17 (44.7)
Family members would be too busy 2 (5.3)
Seldom see family members 3 (7.9)
Did not want others to know of her history of cancer 1 (2.6)
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which are run by the Department of Health, and
clinics run by the Family Planning Association of Hong
Kong and private practitioners. However, a well-
organised screening programme that covers the entire
special administrative region does not exist. The
availability of present screening services should be
made known to the public, and clinics offering screen-
ing services should be conveniently located and have
flexible opening hours to encourage attendance. The
public should be educated about cervical cancer and
made aware that cervical smear screening can prevent
the development of this disease. Ideally, a uniform
cervical smear screening programme that has clear
guidelines for the frequency of screening—such as
every 3 years, according to the schemes in the United
Kingdom and Canada4,5—and that has efficient call and
recall systems4 should be established in Hong Kong.
References
1. IARC Working Group on Evaluation of Cervical Cancer
Screening Programmes. Screening for squamous cervical
cancer: duration of low risk after negative results of cervical
cytology and its implication for screening policies. Br Med J
(Clin Res Ed) 1986;293:659-64.
2. Adab P. Screening for cervical cancer in Hong Kong [abstract].
Presented at the Fifth Hong Kong International Cancer
Congress; 1998 Nov 10; Hong Kong.
3. Department of Obstetrics and Gynaecology, Queen Mary
Hospital, Hong Kong. Departmental statistics 1995 and 1996.
Hong Kong: Queen Mary Hospital; 1996.
4. 1992 National Health Service Cervical Screening Programme,
National Coordinating Network. In: Duncan ID, editor.
Guidelines for clinical practice and programme management.
London: National Health Service, United Kingdom; 1992.
5. Cervical cancer screening programs. I. Epidemiology and
natural history of carcinoma of the cervix. Can Med Assoc J
1976;114:1003-12.
Instructions for Original Articles
We invite authors to submit Original Articles for publication in future issues of the
Hong Kong Medical Journal.   These should be reports of original research such
as controlled trials, intervention studies, studies of screening and diagnostic tests,
outcome studies, cost-effectiveness analyses, case series, and large-scale
epidemiological studies.  Each manuscript should clearly state an objective; the
design and methodology; the essential features of any interventions; the main
outcome measures; the main results of the study; a discussion placing the results
in the context of published literature; and the conclusions which can be drawn
based on the study.  The text should not exceed 5000 words, the number of tables,
figures, or both should not be more than six, and references not more than 40.
Submitted manuscripts are subject to rigorous review, and acceptance of any
paper cannot be guaranteed.
Interested parties should refer to the Journal’s ‘Information for authors’ which
can be obtained by contacting the Managing Editor, Hong Kong Medical Journal,
10th Floor, 99 Wong Chuk Hang Road, Aberdeen, Hong Kong, China; Fax: (852)
2505 5577/3149; Tel: (852) 2871 8822/8888; or by downloading the relevant file
from the Editorial Office website <http://www.gateway.net.hk/~hkmj/>.
